Value Added Connects

Knowledge Sharing Initiative of Value Added Corporate Services P Ltd, Chennai, India http://www.valueadded.in

Tag Archives: ICMR

ICMR to launch National Registry for ART Clinics in India soon

ICMR to launch National Registry for ART Clinics in India soon

March 27, 2012, 0800 IST


Even as the government is formulating the Assisted Reproductive Technology Bill (ART Bill) to regulate thousands of infertility clinics that have mushroomed in the country over the years, the union health ministry has launched the process of putting in place a comprehensive and authentic central database about the number of such clinics in the country.

As the first stage of the project, the Indian Council of Medical Research (ICMR) is setting up a National Registry of Assisted Reproductive Technology (ART) Clinics in India with a view to providing appropriate help and assistance to all those who are engaged in taking care of infertility problems in the country.

The ART clinics who are engaged in taking care of infertility problems in the country through the practice of any of the 12 techniques should register with the ICMR’s National Registry of ART Clinics in India. These techniques include Artificial Insemination with Husband’s Semen (AIH), Artificial Insemination with Donor Semen (AID), Intra-uterine Insemination using Husband Semen (IUI-H), Intra-uterine Insemination using Donor Semen (IUI-D) and In vitro Fertilization-Embryo Transfer (IVF).

The list of techniques also include Gamete Intrafallopian Tube Transfer (GIFT), Tubal Embryo Transfer (TET), Intracytoplasmic Sperm Injection (ICSI), Percutaneous Epididymal Sperm Aspiration (PESA), Testicular Sperm Aspiration (TESA), Testicular Sperm Extraction (TESE) and Processing or storage of gametes (sperm and oocyte) and or embryos.

Dr R S Sharma, Dy Director General (SG) of the ICMR said that the ICMR has invited all those engaged in using any of the above mentioned procedures to be a part of the registry. Each registrant will be given a Unique Registration No. by the ICMR, which could be used by the registrant in any legitimate purpose.

The ICMR has launched the project as thousands of infertility clinics have mushroomed in the country over the last some years and the government does not have an authentic data about the number of infertility clinics in the country.

Health ministry finalising legislation to regulate fertility clinics in India

Source : Pharmabiz News – September 05, 2011, 0800 IST

Based on the guidelines and norms set by the Indian Council of Medical Research (ICMR), the Union health ministry is finalising a legislation to regulate the growing number of fertility clinics in the country, in view of the rising popularity of the same.

The government has accepted the national guidelines for accreditation, supervision and regulation of Assisted Reproductive Technology (ART) clinics in the country, developed and announced by the ICMR. To effectively implement the guidelines, the ministry is finalising the Assisted Reproductive Technology (Regulation) Bill, sources informed.

The draft of the bill has been published for the comments from the stakeholders. The bill details procedures for accreditation and supervision of infertility clinics (and related organizations such as semen banks) handling spermatozoa or oocytes outside of the body, or dealing with gamete donors and surrogacy, ensuring that the legitimate rights of all concerned are protected, with maximum benefit to the infertile couples/individuals within a recognized framework of ethics and good medical practice.

“It is estimated that 15 per cent of couples around the world are infertile. This implies that infertility is one of the most highly prevalent medical problems. The magnitude of the infertility problem also has enormous social implications. Besides the fact that every couple has the right to have a child, in India infertility widely carries with it a social stigma. In the Indian social context specially, children are also a kind of old age insurance. With the enormous advances in medicine and medical technologies, today 85 per cent of the cases of infertility can be taken care of through medicines, surgery and/or the new medical technologies such as In-Vitro Fertilization (IVF) or intracytoplasmic sperm injection (ICSI),” according to the draft bill.

Most of the new technologies aimed at taking care of infertility, involve handling of the gamete – spermatozoa or the ooctye – outside the body; they also often involve the donation of spermatozoa or oocyte, or the use of a surrogate mother who would be carrying a child with whom she has no biological relationship. These technologies not only require expertise but also open up many avenues for unethical practices which can affect adversely the recipient of the treatment, medically, socially and legally, it said.

The last nearly 20 years have seen an exponential growth of infertility clinics that use techniques requiring handling of spermatozoa or the oocyte outside the body, or the use of a surrogate mother. As of today, anyone can open infertility or ART clinic; no permission is required to do so. There has been, consequently a mushrooming of such clinics around the country.

“In view of the above, in public interest, it has become important to regulate the functioning of such clinics to ensure that the services provided are ethical and that the medical, social and legal rights of all those concerned are protected,” according to the bill.

ICMR issues guidelines for Good Clinical Laboratory Practices

The Indian Council for Medical Research (ICMR) has issued guidelines for Good Clinical Laboratory Practices (GCLP) outlining the principles and procedures to be followed by medical laboratories involved in clinical research and/or patient care so as to provide quality data which can be used for health research and patient treatment. The guidelines aim to explain step wise procedures which should be followed by laboratories to strengthen the quality of test results.

The guidelines specify that GCLP should be followed by all laboratories where tests are done on biological specimens for diagnosis, patient care, disease control and research such as microbiology & serology, haematology & blood banking, molecular biology and molecular pathology, clinical pathology, clinical biochemistry, immunology (immunohaematology and immunobiochemistry), histopathology/pathology and cytology. Each laboratory should identify the scope, functions and the capacity of the services offered by it and appropriate infrastructure with requisite biosafety measures should be planned. Qualified and trained staff should be employed with periodic up-gradation of their skills.

As per the guidelines, the management should facilitate the setting up of biosafety precautions in the laboratory by providing adequate manpower, resources, infrastructure and policy. A biosecurity and/or biosafety officer should be overall in-charge of biosecurity/biosafety in the laboratory. The laboratories should have their own biosafety manual written in consultation with the head of the laboratory. Policies should outline the use of sharps, disposal of bio-waste, reagents, sharps and other wastes generated in the laboratory in accordance with Bio-Medical Waste (Management & Handling) Rules, 1998 (Amended in 2000).

On specimen collection, the guideline stipulates that as this is the first phase of interaction between the patient and the laboratory, appropriate counselling should be done before specimen collection and consent taken whenever needed. Attention should be paid to patient’s sensibilities during the entire process. Any error in specimen collection can lead to erroneous results. It is therefore considered an important step of good clinical laboratory practice and is referred to as ‘preanalytic control’. Specimen collection can be done at the patient’s bedside, in the laboratory or in the field.

Laboratory should have a ‘primary specimen collection manual’, containing information on patient preparation before specimen collection (if any), exact methodology of specimen collection, labelling, handling, transportation and storage of the specimens. In addition, the laboratory should provide adequate and appropriate information/instructions to patients wherever necessary. All preanalytical factors that may influence the test results should be identified. The manual should include guidelines on specimen collection including preservation for histopathological examination. These manuals should be available for reference and should be used for training of staff engaged in specimen collection.

As far as infrastructure is concerned, the guidelines stipulate that the basic infrastructure facilities include: reception room/area where requisition forms are received and reports disbursed; specimen collection room/area; toilets; privacy for special purposes e.g. semen collection; facilities for disabled persons; toilet for staff; quality water supply for analytical purpose; uninterrupted power supply; analytical work area; specimen/sample/slide storage facility including cold storage where applicable; record room/area; facility for cleaning of glassware, sterilization /disinfection; waste disposal facility including biomedical wastes; fire-safety equipment; ventilation, climate control and lighting arrangements; separate room/area for meetings/administrative work; separate facilities/area for staff for hand washing, eating and storing food, drinks etc; communication facility with referral centres; transport of specimen/samples to referral centres and additional infrastructure facilities may be added for special tasks as and when needed.

The GCLP also specifies that each laboratory should designate a head of the laboratory who should be overall in-charge of the daily functioning of the laboratory including administration. A Quality Manager should be designated for monitoring and maintaining of day-to-day quality management system.

On the qualifications and experience of the staff, the guideline outlines that the NABL document 112 (2007) should be followed unless specified by the health care providers. The strength of staff employed should be appropriate to the level of facility and the workload. The roles and responsibilities of the staff should be clearly outlined.

Each laboratory should prepare an exhaustive list of equipment and consumables required and available for general functioning of the laboratory and specialized equipment for special tests. Laboratory equipment should be of adequate capacity to meet work load requirement. New equipment should be calibrated and validated before routine use. AMR (Analytical Measurement Range) should be verified, manufacturer can be consulted for verification and selection of range.

Source : ePharmail of Pharmabiz.com. For more info, visit http://www.pharmabiz.com.

Follow

Get every new post delivered to your Inbox.

Join 311 other followers